Trial Profile
Tolerability and Lipid Lowering Effect of Weekly/Biweekly Crestor in Statin Intolerant Patients Treated With Zetia.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Ezetimibe (Primary) ; Rosuvastatin (Primary)
- Indications Hypercholesterolaemia
- Focus Therapeutic Use
- 11 Sep 2009 New trial record